as 07-26-2024 4:00pm EST
Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Founded: | 2002 | Country: | United States |
Employees: | N/A | City: | N/A |
Market Cap: | 2.3B | IPO Year: | N/A |
Target Price: | $8.00 | AVG Volume (30 days): | 1.4M |
Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.73 | EPS Growth: | N/A |
52 Week Low/High: | $2.99 - $7.74 | Next Earning Date: | 08-09-2024 |
Revenue: | $2,495,258,000 | Revenue Growth: | 9.82% |
Revenue Growth (this year): | 13.47% | Revenue Growth (next year): | -3.87% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Autor Deborah M. | AMRX | Director | May 16 '24 | Sell | $6.76 | 14,553 | $98,378.28 | 116,849 | SEC Form 4 |
Autor Deborah M. | AMRX | Director | May 16 '24 | Sell | $6.73 | 23,447 | $157,727.97 | 93,402 | SEC Form 4 |
AMRX Breaking Stock News: Dive into AMRX Ticker-Specific Updates for Smart Investing
Business Wire
15 days ago
Business Wire
17 days ago
Business Wire
a month ago
Business Wire
a month ago
Business Wire
a month ago
GuruFocus.com
a month ago
Energy Global
a month ago
USA TODAY
a month ago
The information presented on this page, "AMRX Amneal Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.